Compression Therapy Market

Compression Therapy Market by Technique, Product (Bandages, Wraps, Stockings, Tapes, Ortho Braces, Pump), Application (Varicose Vein, DVT, Lymphedema Ulcer), Distribution Channel (Hospitals, Clinics, Pharmacies, E-Commerce) & Region - Global Forecast to 2027

Report Code: MD 5515 Jan, 2023, by marketsandmarkets.com

The global compression therapy market in terms of revenue was estimated to be worth $3.7 billion in 2022 and is poised to reach $4.9 billion by 2027, growing at a CAGR of 5.5% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The large target patient population and the rising incidence of sports injuries and accidents are the major factors driving the growth of this market. Moreover, a strong focus by players on expanding their product offerings in compression therapy is anticipated to support the growth of the market. However, poor patient compliance with compression products is expected to restrain the growth of this market during the forecast period.

Attractive Opportunities in Compression Therapy Market

Compression Therapy Market

To know about the assumptions considered for the study, Request for Free Sample Report

Compression therapy Market Dynamics

Driver: Growing incidence of sports injuries and accidents

Road accidents and sports injuries are among the major causes of death and disability across the globe. Accident cases are often associated with severe or mild injuries to the skeletal system. In such cases, compression therapy products are generally used to support the healing process and promote faster patient recovery.

Globally, an increasing number of people are actively participating in sports and physical activities (as a result of the growing awareness about health and fitness). This trend has, in turn, increased the incidence of sports injuries and injuries related to other physical fitness activities. In the US alone, ~8.6 million sports injuries are registered annually (source: US Department of Health and Human Services, data as of 2021).

Restraint: Low patient compliance with compression garments

Patient non-compliance with compression products and non-adherence to treatment protocols are the common issues related to compression therapy. Noncompliance is especially high in long-term treatments, where the primary goal is to prevent the occurrence of a specific condition (such as the occurrence or reoccurrence of ulcers). Since compression therapy is generally used as a preventive therapy in a majority of cases, the compliance rate of patients with the therapy decreases over time. Moreover, conditions such as pain, swelling, and skin irritation are associated with the regular use of compression garments.

Opportunity: Increased sales of off-the-shelf and online products

Some products (such as low-pressure compression stockings, bandages, and wraps) are increasingly being sold through pharmacies, retailers (off-the-shelf), and e-commerce websites since their use does not require authorization from medical professionals. Such products are regularly used by patients as preventive measures to avoid injuries.

Increasing sales of compression products through e-commerce websites and off-the-shelf channels across mature markets are expected to offer significant growth opportunities for the manufacturers of compression therapy products.

Compression bandages segment accounted for the largest market share of the compression therapy industry, by product.

Based on product, the global compression therapy market is segmented into compression bandages, compression wraps, compression stockings, compression tapes, compression pumps, compression braces, and other compression garments. The market is segmented into compression garments, compression braces, and compression pumps. In 2021, compression bandages are expected to account for the largest share of the global market.

Compression bandages are the first line of treatment for venous diseases and are used to prevent their recurrence during compression therapy. The increasing prevalence of diabetes and the rising geriatric population prone to venous ulcers, foot ulcers, varicose veins, and edema, along with the growing availability of compression bandages in the market, are expected to support the growth of the compression bandages market during the forecast period.

Varicose vein treatment segment accounted for the largest market share of the compression therapy industry by application.

On the basis of application, the compression therapy market is segmented into varicose vein treatment, deep vein thrombosis treatment, lymphedema treatment, leg ulcer treatment, and other applications. The varicose vein treatment segment accounted for the largest market share of the global market during the forecast period, with high preference for compression therapy as the first line of therapy for the treatment and management of varicose veins among end users.

Moreover, the demand for compression therapy products in varicose vein treatment is expected to witness significant growth during the forecast period owing to the growing prevalence of varicose veins as well as the increasing prevalence of major risk factors, such as age-related degeneration, obesity, and hypertension.

Compression Therapy Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The Asia Pacific region of compression therapy industry is expected to grow at the highest CAGR during the forecast period

The compression therapy market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America is expected to account for the largest share of the global market.

Asia Pacific is projected to register the highest growth during the forecast period. This can primarily be attributed to the rising geriatric population along with the growing significant prevalence of orthopaedic and diabetes-related diseases in this population in Asian countries, especially in China and India.

Moreover, the rising per capita healthcare expenditure across emerging Asian countries, increasing localized product manufacturing, and the increasing focus of global product manufacturers on expanding their presence in APAC countries are also supporting the growth of the compression therapy market in Asia Pacific during the forecast period.

The major players in the compression therapy market are DJO Global, Inc. (US), BSN medical (US), medi GmbH & Co. KG (Germany), Tactile Medical (US), SIGVARIS (Switzerland), Sanyleg S.r.l. (Italy), 3M Company (US), ConvaTec Inc. (US), ArjoHuntleigh (Getinge Group, Sweden), and Julius Zorn GmbH (Germany).

Scope of the Compression Therapy Industry

Report Metric

Details

Market Revenue in 2022

$3.7 billion

Projected Revenue by 2027

$4.9 billion

Revenue Rate

Poised to grow at a CAGR of 5.5%

Market Driver

Growing incidence of sports injuries and accidents

Market Opportunity

Increased sales of off-the-shelf and online products

This study categorizes the global compression therapy market to forecast revenue and analyze trends in each of the following submarkets:

By Product

  • Compression Bandages
  • Compression Wraps
  • Compression Stockings
    • Class I
    • Class II
    • Class III
  • Compression Tapes
  • Compression Pumps
    • Intermittent Pumps
    • Sequential Pumps
  • Compression Braces
  • Other Compression Garments*
  • * Other compression garments include foot caps, arm sleeves, gauntlets, compression shirts & bras, chin straps, face masks, and abdominal gloves

By Technique

  • Static Compression Therapy
  • Dynamic Compression Therapy

By Application

  • Varicose Vein Treatment
  • Deep Vein Thrombosis Treatment
  • Lymphedema Treatment
  • Leg Ulcer Treatment
  • Other Applications**
  • Other applications include obstetric applications, rehabilitation/preventive care, aesthetic applications, orthopedic applications, and treatment/management of sports injuries.

By Distribution Channel

  • Pharmacies & Retailers
  • Hospitals & Clinics
  • E-Commerce Platforms
  • Home Care Settings

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • RoE
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • RoLA
  • Middle East & Africa

Recent Developments of Compression Therapy Industry

  • In 2022, DJO acquired the EXCYABIR hip brace and the CryoKnee knee brace from Outcome-based Technologies to build its portfolio of bracing solutions, specifically in the fast-growing hip bracing category.
  • In 2021, Essity acquired with ABIGO Medical. The acquisition added to the company’s wound care product portfolio.
  • In 2021, DJO acquired MedShape, Inc. (US). This acquisition will strengthen DJO’s portfolio of fracture fixation, joint fusion, and soft tissue injury repair products, which utilize biomaterial technologies designed to improve patient outcomes.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 26)
    1.1 STUDY OBJECTIVES 
    1.2 COMPRESSION THERAPY INDUSTRY DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 STUDY SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY 
          TABLE 1 STANDARD CURRENCY CONVERSION RATES
    1.5 LIMITATIONS 
    1.6 KEY MARKET STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
 
2 RESEARCH METHODOLOGY (Page No. - 32)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Indicative list of secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                                FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET ESTIMATION METHODOLOGY 
          FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
           2.2.2 SALES/DISTRIBUTION CHANNEL-BASED MARKET ESTIMATION
                    FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL COMPRESSION THERAPY MARKET
                    FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    2.3 RECESSION IMPACT 
           2.3.1 IMPACT OF RECESSION ON GLOBAL MARKET
    2.4 DATA TRIANGULATION 
          FIGURE 6 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RESEARCH LIMITATIONS 
 
3 EXECUTIVE SUMMARY (Page No. - 44)
    FIGURE 7 COMPRESSION THERAPY MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    FIGURE 8 GLOBAL MARKET SHARE, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
    FIGURE 9 GLOBAL COMPRESSION THERAPY INDUSTRY, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 10 GLOBAL MARKET SHARE, BY DISTRIBUTION CHANNEL, 2022 VS. 2027
    FIGURE 11 GEOGRAPHICAL SNAPSHOT OF GLOBAL COMPRESSION THERAPY INDUSTRY
 
4 PREMIUM INSIGHTS (Page No. - 48)
    4.1 COMPRESSION THERAPY MARKET OVERVIEW 
          FIGURE 12 GROWING INCIDENCE OF SPORTS INJURIES AND FAVORABLE CLINICAL EVIDENCE TO DRIVE MARKET GROWTH
    4.2 GLOBAL MARKET SHARE, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 
          FIGURE 13 COMPRESSION PUMPS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
    4.3 GLOBAL MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION) 
          FIGURE 14 STATIC COMPRESSION THERAPY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    4.4 GLOBAL MARKET, BY DISTRIBUTION CHANNEL, 2022 VS. 2027 (USD MILLION) 
          FIGURE 15 HOSPITALS & CLINICS TO ACCOUNT FOR LARGEST SHARE OF GLOBAL MARKET IN 2027
    4.5 GLOBAL MARKET, BY REGION, 2020–2027 
          FIGURE 16 ASIA PACIFIC TO WITNESS FASTEST GROWTH IN MARKET DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 53)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 17 COMPRESSION THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Large target patient population
                                FIGURE 18 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 2050
                    5.2.1.2 Growing incidence of sports injuries and accidents
                                FIGURE 19 EUROPE: ROAD DEATHS PER MILLION INHABITANTS, BY COUNTRY, 2021
                    5.2.1.3 Increasing number of orthopedic procedures
                    5.2.1.4 Greater product affordability and market availability
                    5.2.1.5 Clinical evidence favoring adoption of compression therapy for management of target conditions
           5.2.2 RESTRAINTS
                    5.2.2.1 Lack of universally accepted standards for compression products
                    5.2.2.2 Low patient compliance with compression garments
                                FIGURE 20 REASONS FOR NON-COMPLIANCE TO COMPRESSION THERAPY
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growth potential offered by emerging markets
                    5.2.3.2 Growing patient awareness regarding benefits of compression therapy
                    5.2.3.3 Increased sales of off-the-shelf and online products
           5.2.4 CHALLENGES
                    5.2.4.1 Significant adoption of alternative therapies for specific target indications
                    5.2.4.2 Increasing pricing pressure on market players
    5.3 PORTER’S FIVE FORCES ANALYSIS 
           5.3.1 OVERVIEW
                    TABLE 2 COMPRESSION THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.3.2 BARGAINING POWER OF BUYERS
           5.3.3 BARGAINING POWER OF SUPPLIERS
           5.3.4 THREAT FROM NEW ENTRANTS
           5.3.5 THREAT FROM SUBSTITUTES
           5.3.6 INTENSITY OF COMPETITIVE RIVALRY
    5.4 PRICING TREND ANALYSIS 
           5.4.1 AVERAGE SELLING PRICE, BY PRODUCT
                    TABLE 3 AVERAGE PRICE OF KEY COMPRESSION THERAPY PRODUCTS, 2021 (USD)
           5.4.2 AVERAGE SELLING PRICE, BY REGION
                    TABLE 4 REGIONAL PRICING ANALYSIS OF KEY COMPRESSION THERAPY PRODUCTS, 2021 (USD)
    5.5 TECHNOLOGY ANALYSIS 
           5.5.1 WIRELESS BIOSENSORS
           5.5.2 GARMENT MANUFACTURING TECHNOLOGIES
    5.6 REGULATORY ANALYSIS 
           5.6.1 NORTH AMERICA
                    5.6.1.1 US
                                TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION
                                TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                    5.6.1.2 Canada
                                TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                                FIGURE 21 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
           5.6.2 EUROPE
                    FIGURE 22 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
           5.6.3 ASIA PACIFIC
                    5.6.3.1 Japan
                                TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
                    5.6.3.2 China
                                TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.6.3.3 India
    5.7 REIMBURSEMENT SCENARIO 
          TABLE 10 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES AS OF 2021
    5.8 VALUE CHAIN ANALYSIS 
          FIGURE 23 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
    5.9 SUPPLY CHAIN ANALYSIS 
           5.9.1 PROMINENT COMPANIES
           5.9.2 SMALL & MEDIUM-SIZED ENTERPRISES
           5.9.3 END USERS
                    FIGURE 24 SUPPLY CHAIN ANALYSIS
    5.10 ECOSYSTEM ANALYSIS 
           5.10.1 PARENT MARKET: ORTHOPEDIC IMPLANTS, SURGICAL DEVICES, AND SUPPORT PRODUCTS
    5.11 PATENT ANALYSIS 
           FIGURE 25 PATENT ANALYSIS
    5.12 TRADE ANALYSIS 
           TABLE 11 IMPORT DATA FOR COMPRESSION STOCKINGS (HS CODE 611510), BY COUNTRY, 2017–2021 (USD)
           TABLE 12 EXPORT DATA FOR COMPRESSION STOCKINGS (HS CODE 611510), BY COUNTRY, 2017–2021 (USD)
    5.13 KEY CONFERENCES & EVENTS, 2022–2023 
           5.13.1 GLOBAL COMPRESSION THERAPY INDUSTRY: LIST OF MAJOR CONFERENCES & EVENTS
    5.14 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS, BY DISTRIBUTION CHANNEL
                     FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY DISTRIBUTION CHANNEL
                     TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY DISTRIBUTION CHANNEL (%)
           5.14.2 BUYING CRITERIA
                     FIGURE 27 KEY BUYING CRITERIA, BY DISTRIBUTION CHANNEL
                     TABLE 14 KEY BUYING CRITERIA, BY DISTRIBUTION CHANNEL
 
6 COMPRESSION THERAPY MARKET, BY TECHNIQUE (Page No. - 86)
    6.1 INTRODUCTION 
          TABLE 15 GLOBAL COMPRESSION THERAPY INDUSTRY, BY TECHNIQUE, 2020–2027 (USD MILLION)
    6.2 STATIC COMPRESSION THERAPY 
           6.2.1 PROCEDURAL ADVANTAGES OF STATIC COMPRESSION THERAPY TO DRIVE GROWTH
                    TABLE 16 STATIC GLOBAL MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.3 DYNAMIC COMPRESSION THERAPY 
           6.3.1 RISING INCIDENCE OF TARGET CONDITIONS TO SUPPORT MARKET
                    TABLE 17 DYNAMIC GLOBAL MARKET, BY REGION, 2020–2027 (USD MILLION)
 
7 COMPRESSION THERAPY MARKET, BY PRODUCT (Page No. - 90)
    7.1 INTRODUCTION 
          TABLE 18 GLOBAL COMPRESSION THERAPY INDUSTRY, BY PRODUCT, 2020–2027 (USD MILLION)
    7.2 COMPRESSION BANDAGES 
           7.2.1 LIMITED AVAILABILITY OF MEDICAL REIMBURSEMENTS FOR VARICOSE VEIN SURGERIES TO RESTRAIN MARKET GROWTH
                    TABLE 19 COMPRESSION BANDAGES MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 20 COMPRESSION BANDAGES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                    TABLE 21 COMPRESSION BANDAGES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 22 COMPRESSION BANDAGES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
    7.3 COMPRESSION WRAPS 
           7.3.1 RISING GERIATRIC POPULATION AND INCREASING INCIDENCE OF SPORTS INJURIES TO DRIVE MARKET
                    TABLE 23 COMPRESSION WRAPS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 24 COMPRESSION WRAPS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                    TABLE 25 COMPRESSION WRAPS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 26 COMPRESSION WRAPS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
    7.4 COMPRESSION STOCKINGS 
          TABLE 27 COMPRESSION STOCKINGS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 28 COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 29 COMPRESSION STOCKINGS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
          TABLE 30 COMPRESSION STOCKINGS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
          TABLE 31 COMPRESSION STOCKINGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
           7.4.1 CLASS I COMPRESSION STOCKINGS
                    7.4.1.1 Advantages such as comfort and durability to drive demand for class I stockings
                                TABLE 32 CLASS I COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)
           7.4.2 CLASS II COMPRESSION STOCKINGS
                    7.4.2.1 Increasing number of lymphedema and DVT patients to fuel demand
                                TABLE 33 CLASS II COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)
           7.4.3 CLASS III COMPRESSION STOCKINGS
                    7.4.3.1 High level of compression provided to boost adoption of class III stockings
                                TABLE 34 CLASS III COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.5 COMPRESSION TAPES 
           7.5.1 ABILITY TO PREVENT FURTHER MUSCLE INJURY TO DRIVE DEMAND FOR COMPRESSION TAPES
                    TABLE 35 COMPRESSION TAPES MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 36 COMPRESSION TAPES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                    TABLE 37 COMPRESSION TAPES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 38 COMPRESSION TAPES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
    7.6 COMPRESSION PUMPS 
          TABLE 39 COMPRESSION PUMPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 40 COMPRESSION PUMPS MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 41 COMPRESSION PUMPS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
          TABLE 42 COMPRESSION PUMPS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
          TABLE 43 COMPRESSION PUMPS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
           7.6.1 INTERMITTENT PUMPS
                    7.6.1.1 Availability of wide range of intermittent pumps with varying designs and complexity to boost demand
                                TABLE 44 INTERMITTENT COMPRESSION PUMPS MARKET, BY REGION, 2020–2027 (USD MILLION)
           7.6.2 SEQUENTIAL PUMPS
                    7.6.2.1 Wide usage to prevent development of DVT to boost growth
                                TABLE 45 SEQUENTIAL COMPRESSION PUMPS MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.7 COMPRESSION BRACES 
           7.7.1 RISING NUMBER OF JOINT REPLACEMENT SURGERIES TO SUPPORT MARKET
                    TABLE 46 COMPRESSION BRACES MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 47 COMPRESSION BRACES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                    TABLE 48 COMPRESSION BRACES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 49 COMPRESSION BRACES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
    7.8 OTHER COMPRESSION GARMENTS 
          TABLE 50 OTHER COMPRESSION GARMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 51 OTHER COMPRESSION GARMENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
          TABLE 52 OTHER COMPRESSION GARMENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
          TABLE 53 OTHER COMPRESSION GARMENTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
 
8 COMPRESSION THERAPY MARKET, BY APPLICATION (Page No. - 112)
    8.1 INTRODUCTION 
          TABLE 54 GLOBAL COMPRESSION THERAPY INDUSTRY, BY APPLICATION, 2020–2027(USD MILLION)
    8.2 VARICOSE VEIN TREATMENT 
           8.2.1 GROWING GLOBAL PREVALENCE OF VARICOSE VEINS TO DRIVE MARKET
                    TABLE 55 GLOBAL MARKET FOR VARICOSE VEIN TREATMENT, BY REGION, 2020–2027 (USD MILLION)
    8.3 DEEP VEIN THROMBOSIS TREATMENT 
           8.3.1 AVAILABILITY OF ALTERNATIVE TREATMENTS FOR DVT TO LIMIT GROWTH
                    TABLE 56 GLOBAL MARKET FOR DEEP VEIN THROMBOSIS TREATMENT, BY REGION, 2020–2027 (USD MILLION)
    8.4 LYMPHEDEMA TREATMENT 
           8.4.1 RISING INCIDENCE OF CANCER TO CONTRIBUTE TO GROWTH
                    TABLE 57 GLOBAL MARKET FOR LYMPHEDEMA TREATMENT, BY REGION, 2020–2027 (USD MILLION)
    8.5 LEG ULCER TREATMENT 
           8.5.1 GROWING DISEASE BURDEN ACROSS MAJOR COUNTRIES TO BOOST MARKET
                    TABLE 58 GLOBAL MARKET FOR LEG ULCER TREATMENT, BY REGION, 2020–2027 (USD MILLION)
    8.6 OTHER APPLICATIONS 
          TABLE 59 GLOBAL MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
 
 
9 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL (Page No. - 120)
    9.1 INTRODUCTION 
          TABLE 60 GLOBAL COMPRESSION THERAPY INDUSTRY, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
    9.2 PHARMACIES & RETAILERS 
           9.2.1 RISING ADOPTION OF OFF-THE-SHELF PRODUCTS TO SUPPORT MARKET GROWTH
                    TABLE 61 GLOBAL MARKET FOR PHARMACIES & RETAILERS, BY REGION, 2020–2027 (USD MILLION)
    9.3 E-COMMERCE PLATFORMS 
           9.3.1 E-COMMERCE PLATFORMS TO REGISTER HIGH CAGR DURING FORECAST PERIOD
                    TABLE 62 GLOBAL MARKET FOR E-COMMERCE PLATFORMS, BY REGION, 2020–2027 (USD MILLION)
    9.4 HOSPITALS & CLINICS 
           9.4.1 HEALTHCARE INFRASTRUCTURAL IMPROVEMENTS TO BOOST GROWTH
                    TABLE 63 GLOBAL MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION)
    9.5 HOME CARE SETTINGS 
           9.5.1 GROWING INCLINATION TOWARD HOME HEALTHCARE TO DRIVE MARKET
                    TABLE 64 GLOBAL MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION)
 
10 COMPRESSION THERAPY MARKET, BY REGION (Page No. - 126)
     10.1 INTRODUCTION 
             TABLE 65 GLOBAL COMPRESSION THERAPY INDUSTRY, BY REGION, 2020–2027 (USD MILLION)
     10.2 NORTH AMERICA 
             FIGURE 28 NORTH AMERICA: COMPRESSION THERAPY MARKET SNAPSHOT
             TABLE 66 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 67 NORTH AMERICA: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             TABLE 68 NORTH AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 69 NORTH AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 70 NORTH AMERICA: MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
             10.2.1 US
                        10.2.1.1 Rising number of sports injuries to drive market growth
                                      TABLE 71 US: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Increasing incidence of target diseases to support growth
                                      TABLE 72 CANADA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
     10.3 EUROPE 
             TABLE 73 EUROPE: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 74 EUROPE: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             TABLE 75 EUROPE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 76 EUROPE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 77 EUROPE: MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Inconsistent reimbursement for compression therapy products to restrain market growth
                                      TABLE 78 GERMANY: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Rising prevalence of lymphedema and DVT to drive market
                                      TABLE 79 UK: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 High incidence of diabetes to drive demand for compression therapy
                                      TABLE 80 FRANCE: COMPRESSION THERAPY INDUSTRY, BY PRODUCT, 2020–2027 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Rising awareness about preventive care for musculoskeletal injuries to fuel growth
                                      TABLE 81 ITALY: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Growing presence of key manufacturers to increase access to compression therapy products
                                      TABLE 82 SPAIN: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.3.6 REST OF EUROPE
                        TABLE 83 HIP AND KNEE SURGERY PROCEDURES (PER 100,000 PEOPLE) IN EUROPEAN COUNTRIES
                        TABLE 84 REST OF EUROPE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
     10.4 ASIA PACIFIC 
             FIGURE 29 ASIA PACIFIC: MARKET SNAPSHOT
             TABLE 85 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 86 ASIA PACIFIC: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             TABLE 87 ASIA PACIFIC: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 88 ASIA PACIFIC: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 89 ASIA PACIFIC: MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
             10.4.1 JAPAN
                        10.4.1.1 Japan to dominate Asia Pacific compression therapy market
                                      TABLE 90 JAPAN: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 Modernization of healthcare facilities to drive market growth
                                      TABLE 91 CHINA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Growing number of hip & knee surgeries to support market
                                      TABLE 92 INDIA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.4.4 AUSTRALIA
                        10.4.4.1 Government subsidies related to compression garments for lymphedema patients to promote growth
                                      TABLE 93 AUSTRALIA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.4.5 SOUTH KOREA
                        10.4.5.1 Increasing number of plastic surgeries to drive demand for compression garments
                                      TABLE 94 SOUTH KOREA: COMPRESSION THERAPY INDUSTRY, BY PRODUCT, 2020–2027 (USD MILLION)
             10.4.6 REST OF ASIA PACIFIC
                        TABLE 95 REST OF ASIA PACIFIC: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
     10.5 LATIN AMERICA 
             TABLE 96 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 97 LATIN AMERICA: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             TABLE 98 LATIN AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 99 LATIN AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 100 LATIN AMERICA: MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
             10.5.1 BRAZIL
                        10.5.1.1 Rising number of cosmetic surgeries to support market
                                      TABLE 101 BRAZIL: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.5.2 MEXICO
                        10.5.2.1 Lack of reimbursement for bracing products to limit growth
                                      TABLE 102 MEXICO: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             10.5.3 REST OF LATIN AMERICA
                        TABLE 103 REST OF LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA 
             10.6.1 UNFAVORABLE REIMBURSEMENT SCENARIO TO HAMPER MARKET GROWTH
                        TABLE 104 MIDDLE EAST & AFRICA: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                        TABLE 105 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 106 MIDDLE EAST & AFRICA: COMPRESSION THERAPY INDUSTRY, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 107 MIDDLE EAST & AFRICA: MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION)
 
11 COMPETITIVE LANDSCAPE (Page No. - 162)
     11.1 INTRODUCTION 
     11.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN COMPRESSION THERAPY MARKET
                        TABLE 108 STRATEGIES ADOPTED BY KEY COMPRESSION THERAPY PRODUCT MANUFACTURING COMPANIES
     11.3 REVENUE SHARE ANALYSIS 
             FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN GLOBAL COMPRESSION THERAPY INDUSTRY
     11.4 MARKET SHARE ANALYSIS 
             FIGURE 31 GLOBAL COMPRESSION THERAPY INDUSTRY SHARE, BY KEY PLAYER, 2021
     11.5 COMPETITIVE SITUATIONS AND TRENDS 
             TABLE 109 GLOBAL COMPRESSION THERAPY INDUSTRY: DEGREE OF COMPETITION
     11.6 COMPANY EVALUATION QUADRANT 
     11.7 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2021) 
             11.7.1 STARS
             11.7.2 EMERGING LEADERS
             11.7.3 PERVASIVE PLAYERS
             11.7.4 PARTICIPANTS
                        FIGURE 32 GLOBAL MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
     11.8 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (2021) 
             11.8.1 PROGRESSIVE COMPANIES
             11.8.2 STARTING BLOCKS
             11.8.3 RESPONSIVE COMPANIES
             11.8.4 DYNAMIC COMPANIES
                        FIGURE 33 GLOBAL MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) (2021)
     11.9 COMPETITIVE BENCHMARKING 
             FIGURE 34 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN GLOBAL COMPRESSION THERAPY INDUSTRY
             TABLE 110 COMPANY PRODUCT FOOTPRINT
             TABLE 111 COMPANY REGIONAL FOOTPRINT
     11.1 COMPETITIVE SCENARIO 
             11.10.1 PRODUCT LAUNCHES
             11.10.2 DEALS
             11.10.3 OTHER DEVELOPMENTS
 
12 COMPANY PROFILES (Page No. - 173)
     12.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             12.1.1 3M
                        TABLE 112 3M: BUSINESS OVERVIEW
                        FIGURE 35 3M: COMPANY SNAPSHOT (2021)
             12.1.2 ARJOHUNTLEIGH
                        TABLE 113 ARJOHUNTLEIGH: BUSINESS OVERVIEW
                        FIGURE 36 ARJOHUNTLEIGH: COMPANY SNAPSHOT (2021)
             12.1.3 BIO COMPRESSION SYSTEMS, INC.
                        TABLE 114 BIO COMPRESSION SYSTEMS, INC.: BUSINESS OVERVIEW
             12.1.4 BSN MEDICAL (A SUBSIDIARY OF ESSITY)
                        TABLE 115 ESSITY: BUSINESS OVERVIEW
                        FIGURE 37 ESSITY: COMPANY SNAPSHOT (2021)
             12.1.5 CARDINAL HEALTH, INC.
                        TABLE 116 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
                        FIGURE 38 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022)
             12.1.6 CONVATEC INC.
                        TABLE 117 CONVATEC INC.: BUSINESS OVERVIEW
                        FIGURE 39 CONVATEC INC.: COMPANY SNAPSHOT (2021)
             12.1.7 DJO, LLC (A SUBSIDIARY OF COLFAX CORPORATION)
                        TABLE 118 DJO, LLC: BUSINESS OVERVIEW
                        FIGURE 40 COLFAX CORPORATION: COMPANY SNAPSHOT (2021)
             12.1.8 JULIUS ZORN GMBH
                        TABLE 119 JULIUS ZORN GMBH: BUSINESS OVERVIEW
             12.1.9 MEDI GMBH & CO. KG
                        TABLE 120 MEDI GMBH & CO. KG: BUSINESS OVERVIEW
             12.1.10 PAUL HARTMANN AG
                        TABLE 121 PAUL HARTMANN AG: BUSINESS OVERVIEW
                        FIGURE 41 PAUL HARTMANN AG: COMPANY SNAPSHOT (2021)
             12.1.11 SANYLEG S.R.L.
                        TABLE 122 SANYLEG S.R.L.: BUSINESS OVERVIEW
             12.1.12 SIGVARIS GROUP
                        TABLE 123 SIGVARIS GROUP: BUSINESS OVERVIEW
             12.1.13 SMITH & NEPHEW PLC
                        TABLE 124 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
                        FIGURE 42 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2021)
             12.1.14 TACTILE SYSTEMS TECHNOLOGY, INC. (“TACTILE MEDICAL”)
                        TABLE 125 TACTILE MEDICAL: BUSINESS OVERVIEW
                        FIGURE 43 TACTILE MEDICAL: COMPANY SNAPSHOT (2021)
             12.1.15 MEGO AFEK LTD.
                        TABLE 126 MEGO AFEK LTD.: BUSINESS OVERVIEW
     12.2 OTHER PLAYERS 
             12.2.1 MEDLINE INDUSTRIES, LP
             12.2.2 GOTTFRIED MEDICAL, INC.
             12.2.3 THERMOTEK, INC.
             12.2.4 BAUERFEIND AG
             12.2.5 OFA BAMBERG GMBH
             12.2.6 ACI MEDICAL, LLC
             12.2.7 AIROS MEDICAL INC.
             12.2.8 BARCELCOM TÊXTEIS, S.A.
             12.2.9 CIZETA MEDICALI S.P.A.
             12.2.10 BÖSL MEDIZINTECHNIK
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
13 APPENDIX (Page No. - 223)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 

This study involved four major activities in estimating the current size of the compression therapy market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were used to estimate the total market size. After that, the market breakdown and data triangulation were done to determine the market size of the segments and sub-segments.

Secondary Research

The secondary sources referred to in this research study include corporate filings (such as annual reports, SEC filings, investor presentations, and financial statements); research journals; and press releases; trade, business, and professional associations. Secondary sources were used to identify and collect useful information for this extensive and commercial study of the global market. Secondary research was mainly used to obtain key information about the industry’s total pool of key players, market classification and segmentation according to industry trends to the bottom-most level, market trends, and critical developments by both the public and private organizations in the compression therapy market.

The secondary sources referred to for this research study include government sources, independent or public sources, paid/private databases, and research databases, among others. Secondary data was collected and analyzed to arrive at the overall market size of the compression therapy market, which was further validated by primary research. Some of the key secondary sources referred to during the preparation of this report are listed below-

  • Governmental and Intergovernmental Sources & Databases such as World Health Organization (WHO), World Bank, Organisation for Economic Co-operation and Development (OECD), Centers for Disease Control and Prevention (CDC), National Health Service (NHS) among others
  • Business and Research Articles: Springer Nature, The Lancet, PubMed, and US National Library of Medicine, among others
  • Company Sources: Annual reports, SEC filings, regulatory filings, investor presentations, press releases, and financial statements, among others.

Primary Research

Extensive primary research was conducted after acquiring knowledge about the compression therapy market scenario. The compression therapy market comprises several stakeholders, such as end-product manufacturers, raw material providers, and end-users in the supply chain. The demand side of this market is characterized by its end-users, such as hospitals & clinics, pharmacies and retailers, e-commerce platforms, among others. The supply-side is characterized by raw material providers, integrators, and others. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

A breakdown of the primary respondents is provided below:

Compression Therapy Market Size, and Share

*C-level primaries include CEOs, CFOs, COOs, and VPs.

**Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue; as of 2021, Tier 1 = >USD 10 billion, Tier 2 = USD 1 billion to USD 10 billion, and Tier 3 = <USD 1 billion.

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches have been used to estimate and validate the size of the compression therapy market and its dependent submarkets. These methods were also used extensively to determine the extent of various sub-segments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and demand have been identified through extensive secondary research, and their market share has been determined through both primary and secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.  
  • All the possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
  • The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Compression Therapy Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the whole market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the end-use industries.

Report Objectives

  • To define, describe, and forecast the compression therapy market based on product, technique, application, distribution channel, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the revenue of the market segments with respect to five major regions and their countries—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To strategically profile the key global players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as product launches, upgrades, and approvals; partnerships, agreements, and collaborations; acquisitions; and expansions in the compression therapy market
  • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes players on various parameters within the broad categories of business and product excellence strategy

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the client’s specific needs. The following customization options are available for the compression therapy market report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top 5 companies

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 5515
Published ON
Jan, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Compression Therapy Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback